Summary
The product Methandrostenolone 10 mg, manufactured by Unique Pharma, was independently tested for authenticity and potency. The sample, identified by batch number UN64365 (expiration date: 06/2027), was submitted by Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis found a concentration of 11.17 mg per tablet, exceeding the labeled claim of 10 mg by 11.7%.
The testing process began on 14 October 2024, with the sample received on 18 October 2024, and analysis completed on 22 October 2024. While the results confirm accurate dosing, it is critical to address potential bias in reseller-submitted samples and encourage third-party validation across multiple batches for comprehensive assurance. This report aims to support harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Methandrostenolone 10 mg
- Active Ingredient: Methandienone
- Batch Number: UN64365
- Expiration Date: 06/2027
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #50938
- Testing Ordered: 14 October 2024
- Sample Received: 18 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Labeled Specification: 10 mg/tablet
- Measured Concentration: 11.17 mg/tablet
- Accuracy: 111.7% (11.7% above the labeled claim)
Verification Details
- Verification URL: https://janoshik.com/tests/50938_654QPZXQG4G2
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
The analysis confirms that Methandrostenolone 10 mg tablets are slightly overdosed, reflecting strong quality control for this batch. However, scrutiny is advised as the sample was submitted and funded by the reseller, Opitropin.EU, potentially introducing bias. Resellers may select optimal batches for testing, which might not represent overall product consistency. To ensure transparency, independent third-party testing across different batches is recommended.
Conclusion
The test confirms that Methandrostenolone 10 mg tablets contain 11.17 mg of Methandienone, exceeding the labeled dosage. This batch showcases excellent quality control, though broader testing is essential to validate product consistency. The findings aim to promote harm reduction and informed consumer decisions.
Disclaimer
This report is published solely for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases but provides useful data when critically evaluated alongside independent third-party results. Readers are advised to use this information responsibly.
